Trial exclusion patterns Phase 2 and Phase 3 retatrutide trials commonly excluded participants with a history of pancreatitis, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), severe gastroparesis, recent major cardiovascular events, severe kidney impairment, type 1 diabetes (in the obesity studies), and pregnancy or breastfeeding
For context, see What Is GLP-1
By replenishing NAD+ levels with an NAD+ Drip, we can potentially boost cellular energy production, leading to increased vitality and a reduction in age-related symptoms
A study has also demonstrated that L-carnitine can lower oxidative stress placed on spermatozoa
A literature review on "body positivity": a topical trend from different points of view
Professional Guidance Work with a knowledgeable healthcare provider before starting peptides